News

Clinical data confirms elimination of requirement for finger-stick calibration, de-risking pathway to commercialization for ...
The company said its CGM+ system can deliver accurate readings across a 15-day lifespan, while also employing fewer ...
Trinity Biotech plc TRIB announced compelling positive clinical trial results with respect to its next-generation continuous glucose monitoring (CGM) technology, CGM+, on Tuesday. The trial data ...
An update from Trinity Biotech ( ($TRIB) ) is now available. On August 12, 2025, Trinity Biotech announced breakthrough clinical trial results for ...
Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029 News provided by Trinity Biotech plc Jan 28, 2025, 7:20 AM ET ...
David Ouston, Biosensor Marketing Director of Trinity Biotech, said, “We’ve made significant progress in the development of our next generation CGM, with an innovative reimagining of our ...
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 ...
Trinity Biotech (TRIB) stock gains on encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose monitoring ( (CGM)) system. Read more here.
Trinity plans to submit regulatory filings in Europe in 2025, followed by a U.S. FDA filing in 2026, and further pre-pivotal trials are set to begin in Q1 2025. TRIB closed Wednesday's (FEB.05 ...
Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology Provided by GlobeNewswire Jan 28, 2025 4:20am ...
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
Trinity Biotech plc has announced encouraging results from its recent pre-pivotal clinical trial of its next-generation continuous glucose monitoring (CGM) system, targeting diabetes management ...